Nicholas Augustinos - 18 May 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Nicholas Augustinos
Issuer symbol
DXCM
Transactions as of
18 May 2023
Net transactions value
+$3.04
Form type
4
Filing time
22 May 2023, 15:49:48 UTC
Previous filing
23 May 2022
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $3.04 +3,043 +77% $0.001000* 7,019 18 May 2023 Direct F1
transaction DXCM Common Stock Gift $0 -3,976 -57% $0.000000 3,043 18 May 2023 Direct F2
transaction DXCM Common Stock Gift $0 +3,976 +12% $0.000000 38,016 18 May 2023 by Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.
F3 Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.